Exploring the Science and Appreciating the Patient Experience: Early, Individualized Therapy to Optimize Outcomes in Multiple Sclerosis

Wednesday, November 20, 2019
6:00 PM – 8:30 PM
Malone’s Prime
3373 Tates Creek Road
Lexington, KY 40502



6:00 PM – 6:30 PM       Registration
6:30 AM – 8:00 PM       Practitioner’s EdgeSM  Scientific Session
8:00 PM – 8:15 PM       Question & Answer Session



Patricia K. Coyle, MD
Professor of Neurology and Vice Chair of Clinical Affairs
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York


Multiple sclerosis (MS) is a progressive, immune-mediated, neurodegenerative disease that is associated with irreversible physical disability and functional impairment. Due to its heterogeneity, treatment of patients with MS is highly individualized. This activity is designed to help neurologists integrate the latest clinical evidence on disease-modifying therapies (DMTs) with patient needs and preferences to develop effective, individualized treatment plans. During this interactive case-based activity, learners will balance the benefits and risks of MS treatment options to optimize patient management through shared decision-making.


Practitioner’s EdgeSM Workshops are innovative, interactive meetings that provide attendees with cutting edge medical education in a peer-to-peer discussion setting. Practitioner’s EdgeSM provides the practicing healthcare provider with tools and education that may be utilized immediately in daily practice.

In this Practitioner’s EdgeSM program, case studies will be utilized to illustrate issues related to patients with MS. Audience participation will be invited via interactive questions interspersed throughout the program. The results of the interactive questions will serve as a catalyst for faculty discussion and best-practice reinforcement.


This educational initiative has been designed for MS specialists, neurologists, internists, and allied healthcare professionals in MS centers.


Upon completion of this educational activity, participants should be able to:

  • Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage
  • Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans
  • Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT
  • Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS


Registration for this program is full. Please call Integrity Continuing Education, Inc. at 1-855-835-4004 with any questions.


Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

A detailed disclosure for all persons in control of content, including faculty presenters, will be provided at the live event.


The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.


Provided by Integrity Continuing Education, Inc.

Supported by independent educational grants from Biogen MA, Inc. and Novartis Pharmaceuticals Corporation. This activity was supported by an educational grant from Celgene Corporation.


6:00 PM – 6:30 PM       Registration
6:30 AM – 8:00 PM       Practitioner’s Edge SM  Scientific Session
8:00 PM – 8:15 PM       Question & Answer Session